Literature DB >> 31695254

A Novel Phosphoinositide-3-kinase Adapter Protein 1 Gene Missense Mutation in Familial Cirrhosis.

Cyriac Abby Philips1, Meenal Agarwal2, Nikhil Phadke3, Sasidharan Rajesh1, Guruprasad Padsalgi1, Rizwan Ahamed1, Philip Augustine1.   

Abstract

Familial cirrhosis is a condition that is associated with the presence of liver disease with genetic linkage among multiple family members in a generation or in multiple generations. With cirrhosis, most of these disease pathogeneses are related to a defect of an enzyme/transport protein leading to a deranged metabolic pathway with variable prevalence. Many studies and high-quality metanalyses have shed light on genetic linkage associated with nonalcoholic fatty liver disease and steatohepatitis such as the PNPLA3, MBOAT7, and TM6SF2 variants. In this report, we shed light on a novel missense mutation associated with cirrhosis in a family of brothers associated with phosphoinositide-3-kinase adapter protein 1 gene through high-output whole exosome gene sequencing methodology.
© 2019 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CCDS, Consensus Coding Sequence; DNA, Deoxyribonucleic acid; EWAS, Epigenome wide association study; GWAS, Genome-wide association studies; HCC, Hepatocellular carcinoma; HGVS, Human Genome Variation Society; MBOAT7, Membrane bound O-acyltransferase domain-containing 7; NAFLD, Non-alcoholic fatty liver disease; NGS, Next generation sequencing; OMIM, Online Mendelian Inheritance in Man; PBC, Primary biliary cholangitis; PI3K; PIK3AP1, Phosphoinositide-3-Kinase Adapter Protein 1; PNPLA3; PNPLA3, Patatin-like phospholipase domain containing 3; RNA, Ribosomal nucleic acid; RefSeq, Reference Sequence Database; TMC4, Transmembrane channel-like 4 gene; chronic liver disease; epigenetics; exosome; familial cirrhosis; gene mutation; genomics; illumina; linkage; metagenome; missense mutation

Year:  2019        PMID: 31695254      PMCID: PMC6823681          DOI: 10.1016/j.jceh.2019.02.002

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  15 in total

Review 1.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

2.  Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.

Authors:  Paola Dongiovanni; Salvatore Petta; Cristina Maglio; Anna Ludovica Fracanzani; Rosaria Pipitone; Enrico Mozzi; Benedetta Maria Motta; Dorota Kaminska; Raffaela Rametta; Stefania Grimaudo; Serena Pelusi; Tiziana Montalcini; Anna Alisi; Marco Maggioni; Vesa Kärjä; Jan Borén; Pirjo Käkelä; Vito Di Marco; Chao Xing; Valerio Nobili; Bruno Dallapiccola; Antonio Craxi; Jussi Pihlajamäki; Silvia Fargion; Lars Sjöström; Lena M Carlsson; Stefano Romeo; Luca Valenti
Journal:  Hepatology       Date:  2015-02       Impact factor: 17.425

3.  Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.

Authors:  Cyrielle Caussy; Meera Soni; Jeffrey Cui; Ricki Bettencourt; Nicholas Schork; Chi-Hua Chen; Mahdi Al Ikhwan; Shirin Bassirian; Sandra Cepin; Monica P Gonzalez; Michel Mendler; Yuko Kono; Irine Vodkin; Kristin Mekeel; Jeffrey Haldorson; Alan Hemming; Barbara Andrews; Joanie Salotti; Lisa Richards; David A Brenner; Claude B Sirlin; Rohit Loomba
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

Review 4.  Targeting the PI3K pathway in cancer: are we making headway?

Authors:  Filip Janku; Timothy A Yap; Funda Meric-Bernstam
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

5.  The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.

Authors:  Rosellina Margherita Mancina; Paola Dongiovanni; Salvatore Petta; Piero Pingitore; Marica Meroni; Raffaela Rametta; Jan Borén; Tiziana Montalcini; Arturo Pujia; Olov Wiklund; George Hindy; Rocco Spagnuolo; Benedetta Maria Motta; Rosaria Maria Pipitone; Antonio Craxì; Silvia Fargion; Valerio Nobili; Pirjo Käkelä; Vesa Kärjä; Ville Männistö; Jussi Pihlajamäki; Dermot F Reilly; Jose Castro-Perez; Julia Kozlitina; Luca Valenti; Stefano Romeo
Journal:  Gastroenterology       Date:  2016-02-02       Impact factor: 22.682

Review 6.  Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatology       Date:  2011-05-14       Impact factor: 17.425

Review 7.  Genetic diseases that predispose to early liver cirrhosis.

Authors:  Manuela Scorza; Ausilia Elce; Federica Zarrilli; Renato Liguori; Felice Amato; Giuseppe Castaldo
Journal:  Int J Hepatol       Date:  2014-07-14

8.  Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.

Authors:  Benjamin D Hopkins; Chantal Pauli; Xing Du; Diana G Wang; Xiang Li; David Wu; Solomon C Amadiume; Marcus D Goncalves; Cindy Hodakoski; Mark R Lundquist; Rohan Bareja; Yan Ma; Emily M Harris; Andrea Sboner; Himisha Beltran; Mark A Rubin; Siddhartha Mukherjee; Lewis C Cantley
Journal:  Nature       Date:  2018-07-04       Impact factor: 49.962

9.  TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Authors:  Yang-Lin Liu; Helen L Reeves; Alastair D Burt; Dina Tiniakos; Stuart McPherson; Julian B S Leathart; Michael E D Allison; Graeme J Alexander; Anne-Christine Piguet; Rodolphe Anty; Peter Donaldson; Guruprasad P Aithal; Sven Francque; Luc Van Gaal; Karine Clement; Vlad Ratziu; Jean-Francois Dufour; Christopher P Day; Ann K Daly; Quentin M Anstee
Journal:  Nat Commun       Date:  2014-06-30       Impact factor: 14.919

10.  Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.

Authors:  Shanshan Wang; Mingyue Zhu; Qiaoyun Wang; Yuli Hou; Lei Li; Honglei Weng; Yan Zhao; Dexi Chen; Huiguo Ding; Junli Guo; Mengsen Li
Journal:  Cell Death Dis       Date:  2018-10-09       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.